Option Care Health, Inc. provides home and alternate-site infusion services for patients with acute and chronic conditions across the United States. The company operates in infusion services and reports developments tied to clinical service delivery, national provider relationships, and the economics of its care model.
Recurring news for OPCH includes quarterly and full-year financial results, guidance updates, operating cash flow, share repurchase activity, credit facility changes, and presentations at health care investor conferences. Company updates also address capital allocation and management commentary related to revenue growth and profitability in home and alternate-site infusion care.
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., has announced its participation in two investor conferences. The BofA Securities SMID Cap Ideas Conference will be held virtually on August 10, 2022, featuring a fireside chat at 9:40 am ET. Following that, the Morgan Stanley 20th Annual Global Healthcare Conference is set for September 12, 2022, in New York, with a fireside chat at 8:45 am ET. Additional information and presentations will be available online.
Option Care Health reported strong second quarter 2022 financial results, with net revenue of $980.8 million, a 14.0% increase from $860.3 million in Q2 2021. Gross profit reached $216.9 million (22.1% of revenue), up 9.0% year-over-year. Net income was $33.9 million ($0.19 per share), compared to $31.8 million ($0.18 per share) last year. Adjusted EBITDA increased 17.0% to $85.2 million. Cash flow from operations improved to $104.4 million. The company also completed the acquisition of Specialty Pharmacy Nursing Network for $60.0 million.
Option Care Health (NASDAQ: OPCH) will announce its second-quarter results on July 27, 2022, before market opening. The management team will host a conference call at 8:30 a.m. ET to discuss the results. Option Care Health is recognized as the largest independent provider of home and alternate site infusion services in the U.S., employing over 7,000 individuals, including 4,000 clinicians. The company is dedicated to enhancing patient care for both acute and chronic conditions across all 50 states.
Option Care Health (NASDAQ: OPCH), the largest independent provider of home and alternate site infusion services in the U.S., announced its participation in several upcoming investor conferences. These include the William Blair 42nd Annual Growth Stock Conference on June 7, 2022, the Jefferies Healthcare Conference on June 9, 2022, and the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022. Each event features a fireside chat presentation. More details and webcast links can be found on their investor relations website.
Option Care Health, the largest independent national provider of home infusion services, will participate in the BofA Securities 2022 Healthcare Conference on May 10, 2022, in Las Vegas. The event will feature a fireside chat at 11:20 AM PT, with an audio replay available online afterward. Option Care Health employs over 7,000 team members, including more than 4,000 clinicians, dedicated to improving patient care for acute and chronic conditions across all 50 states. For more information, visit OptionCareHealth.com.
Option Care Health reported a robust first quarter for 2022, achieving net revenue of $915.8 million, a 20.6% increase from $759.2 million in Q1 2021. The gross profit rose to $200.9 million, representing 21.9% of net revenue. The company posted a net income of $30.3 million ($0.17 per share), recovering from a net loss of $2.9 million the prior year. Additionally, Adjusted EBITDA surged by 48.9% to $77.8 million. For 2022, guidance projects revenue between $3.75 billion and $3.90 billion.
Option Care Health (Nasdaq: OPCH) announced the acquisition of Specialty Pharmacy Nursing Network Inc. (SPNN) for $60 million in cash, finalized on April 11, 2022. This acquisition enhances Option Care's nursing capabilities, expanding its team to over 2,900 nurses nationwide. SPNN, a leader in providing specialized nursing resources, will continue its operations as a separate unit within Option Care Health. CEO John Rademacher emphasized that this move aligns with their strategy to improve infusion care and ensures future growth opportunities.
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., announced its first quarter financial results will be released on April 28, 2022. The management team will host a conference call at 8:30 a.m. E.T. to discuss these results. Investors can access the call by phone or through a live audio webcast. A replay will be available for on-demand listening afterward. Option Care Health serves patients with acute and chronic conditions nationwide, employing over 7,000 team members, including more than 4,000 clinicians.
Option Care Health (Nasdaq: OPCH) reported strong financial results for Q4 and full year 2021, with net revenue increasing by 15.2% to $927.2 million in Q4, and by 13.4% to $3,438.6 million for the year. Gross profit rose to $212.2 million in Q4, and net income surged to $75.5 million, driven by a one-time tax benefit. The company also announced the acquisition of Wasatch Infusion LLC and a definitive agreement to acquire Specialty Pharmacy Nursing Network, expected to close in 2022. Full year 2022 guidance projects net revenue of $3.65 to $3.85 billion.
Option Care Health (NASDAQ: OPCH) will release its fourth quarter and full year results for 2021 on February 23, 2022, before market opens. This marks a significant reporting period for the nation's largest independent provider of home and alternate site infusion services. A conference call to discuss the results will be held at 8:30 a.m. E.T. the same day. Interested parties can access the call by dialing (866) 360-3136 or via a live audio webcast at OptionCareHealth's investor relations site.